Oncobiology Symposium
ISSN: 2966-4438
Papers (10)
-
Development of new combination strategies for fist-line chemotherapy with selective cyclin-dependent kinases (CDK) 4/6 inhibitors in colorectal cancer and glioblastoma
Vol 1, 2020 -131595 -
LONCHOCARPIN AND DERRICIN INHIBITS WNT/β-CATENIN SIGNALING AND ENHANCE THE CHEMOTHERAPIC EFFECTS OF 5-FU IN COLORECTAL CANCER CELL LINES
Vol 1, 2020 -131622 -
TP53 REGULATES EXPRESSION OF COLORECTAL CANCERS STEM-CELLS LGR5 BIOMARKER
Vol 1, 2020 -132393 -
DEVELOPMENT OF NEW COMBINATION STRATEGIES FOR FIRST-LINE CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
Vol 2, 2021 -142446 -
p53 impact in colorectal adenocarcinomas and possible role in stem cells niche regulation
Vol 2, 2021 -142578 -
The role of p53 expression in the glioblastoma microenvironment
Vol 2, 2021 -142604 -
LONCHOCARPIN IMPROVES 5-FU IMPACTS ON LONG-TERM SURVIVAL AND PROLIFERATION BY INHIBITING THE CANONICAL WNT PATHWAY IN COLORECTAL CANCER CELLS
Vol 2, 2021 -142679 -
P53 ON THE APPEARANCE OF CANCER STEM CELLS AND EXTRACELLULAR MATRIX CHANGES IN MICE COLORECTAL TUMORS
Vol 3, 2022 -154910 -
DEVELOPMENT OF NEW COMBINATION STRATEGIES OF CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
Vol 3, 2022 -155233 -
β-CATENIN DESTABILIZATION OVERCOMES 5-FU RESISTANCE AND SYNERGISTICALLY IMPAIRS COLORECTAL CANCER GROWTH
Vol 3, 2022 -155263
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
